“All health care practitioners authorized to prescribe or dispense Schedule II-IV controlled substances were required to register to use CURES 2.0 no later than July 1, 2016,” the Dental Board of California reminds dentists in an email distributed late January.
California’s Controlled Substance Utilization Review and Evaluation System, or CURES 2.0
, aids prescribers and dispensers in identifying fraudulent activity and is intended to reduce prescription drug abuse and diversion without affecting legitimate medical practice or patient care. Prescribers will soon be required to check a patient’s prescription history in the CURES 2.0 database prior to prescribing a Schedule II-IV substance in certain situations, with some exemptions.
The dental board “encourages all licensed dentists who hold a DEA registration to take measures immediately to ensure they are in compliance with this CURES 2.0 registration requirement.” One of the following browsers is required to access CURES 2.0: Microsoft Internet Explorer Version 11.0 or greater; Mozilla Firefox; Google Chrome; or Safari.Register to access CURES 2.0
. For CDA resources on CURES and opioid pain management, visit cda.org/opioid
. For assistance with CURES 2.0 registration, contact the CURES helpdesk by email or at 916.227.3843.